Doctors and patients have options to fight high cholesterol beyond statins, and in the works are gene-editing drugs that promise a permanent answer
Patients have options beyond statins, and other alternatives are on the horizon. Source link
Health
Treating gum disease could reduce risk of heart attacks and strokes, study suggests
NEWYou can now listen to Fox News articles! A deep clean at the dentist may benefit more than just your
One toxic behavior kills relationships, leading happiness expert warns
NEWYou can now listen to Fox News articles! Most people spend their lives chasing happiness — or, more often, running
Pfizer has agreed to buy weight-loss drug startup Metsera in a deal that could be worth more than $10 billion, besting rival Novo Nordisk following a heated bidding war
Pfizer prevails over rival Novo Nordisk after an unusual bidding war for the weight-loss startup. Source link
Smoking banned for entire generation, plus tips to stay healthy past age 75
NEWYou can now listen to Fox News articles! Fox News’ Health newsletter brings you stories on the latest developments in
‘What if, despite all available warning signs, I was missing out on a practice that might significantly enhance my life?’ writes Pamela Paul. ‘Could a cold plunge be not only endurable but enjoyable?’
“Am I in shock? Am I about to pass out? I suddenly realize that this is what it feels like
Why most people fall off a ‘health cliff’ at 75 — and 5 ways to avoid the drop
NEWYou can now listen to Fox News articles! Longevity expert Dr. Peter Attia says most people experience a steep decline
Health Care Roundup: Market Talk
Find insight on Novo Nordisk, AstraZeneca, Hikma Pharmaceuticals in the latest Market Talks covering the Health Care sector. Source link
The unlikely duo behind weight-loss drug darling Metsera is about to strike deal gold, for the second time.
The founders of Metsera have a battle to buy their company. It would be their second time striking deal gold.
Real-estate giant Blackstone is liquidating a major investment gone wrong
The investment giant is selling off a portfolio of about 90 properties, in some cases at more than 70% below